Thyroid Cancer and Benign Nodules After ExposureIn Uteroto Fallout From Chernobyl
Autor: | Galyna Zamotayeva, Viktoria Klochkova, Mykola Tronko, Maureen Hatch, Tatiana Bogdanova, Victor Shpak, Mark P. Little, Kiyohiko Mabuchi, Elizabeth K. Cahoon, Vladimir Drozdovitch, Evgeniy Shelkovoy, Galyna Terekhova, Elena Bolshova, Alina V. Brenner |
---|---|
Rok vydání: | 2018 |
Předmět: |
Adult
Male Radioactive Fallout 0301 basic medicine Thyroid nodules medicine.medical_specialty Neoplasms Radiation-Induced Adolescent Republic of Belarus Endocrinology Diabetes and Metabolism Clinical Biochemistry Risk Assessment Biochemistry Gastroenterology Iodine Radioisotopes 03 medical and health sciences 0302 clinical medicine Endocrinology Pregnancy Internal medicine medicine Humans Mass Screening Thyroid Neoplasms Thyroid Nodule Child Thyroid cancer Clinical Research Articles Mass screening Ultrasonography business.industry Biochemistry (medical) Thyroid Dose-Response Relationship Radiation Nodule (medicine) medicine.disease 030104 developmental biology medicine.anatomical_structure Chernobyl Nuclear Accident In utero Child Preschool Prenatal Exposure Delayed Effects 030220 oncology & carcinogenesis Cohort Female medicine.symptom business Risk assessment |
Zdroj: | The Journal of Clinical Endocrinology & Metabolism. 104:41-48 |
ISSN: | 1945-7197 0021-972X |
Popis: | BACKGROUND: Children and adolescents exposed to radioactive iodine-131 (I-131) in fallout from the 1986 Chernobyl nuclear accident appear to be at increased risk of thyroid cancer and benign thyroid nodules. The prenatal period is also considered radiosensitive, and the fetal thyroid can absorb I-131 from the maternal circulation. OBJECTIVES: We aimed to estimate the risk of malignant and benign thyroid nodules in individuals exposed prenatally. METHODS: We studied a cohort of 2582 subjects in Ukraine with estimates of I-131 prenatal thyroid dose (mean = 72.6 mGy), who underwent two standardized thyroid screening examinations. To evaluate the dose-response relationship, we estimated the excess OR (EOR) using logistic regression. RESULTS: Based on a combined total of eight cases diagnosed at screenings from 2003 to 2006 and 2012 to 2015, we found a markedly elevated, albeit not statistically significant, dose-related risk of thyroid cancer (EOR/Gy = 3.91, 95% CI: –1.49, 65.66). At cycle 2 (n = 1,786), there was a strong and significant association between I-131 thyroid dose and screen-detected large benign nodules (≥10 mm) (EOR/Gy = 4.19, 95% CI: 0.68, 11.62; P = 0.009), but no significant increase in risk for small nodules ( |
Databáze: | OpenAIRE |
Externí odkaz: |